Since the discovery of prontosil rubrum by Domagk, a large volume of literature has been published recording the results obtained both in the laboratory, as well as clinically, with drugs belonging or related to sulphanilamides. As the latter are being used more extensively and in bigger doses the dangers which may be associated with their administration are more and more appreciated and any further observation on the subject should be welcome.
Amongst the toxic symptoms observed since the early days of prontosil therapy cyanosis is by far the commonest. It is not associated with any respiratory distress and investigations have shown that it is not necessarily accompanied in all cases by a change in the blood pigment. It seems more likely that it is due to the formation of a pigment in the body from the condensation products of the drug itself (Marshall and Walzl, 1937) . Posner and his colleagues (1938) described a highly unstable form of methsemoglobin which they thought, might account for cyanosis in some of these cases. In many instances, however, the cyanosis is associated with sulph-or methaemoglobinaemia (both intracorpuscular). Sulphaemoglobinsemia is due to the union of the intestinal sulphuretted hydrogen with haemoglobin, a reaction which is catalysed by sulphanilamides. This untoward effect may be avoided by withholding purgatives, except very mild ones like liquid paraffin, by giving a low residue diet and excluding articles containing sulphur, eggs, onions, garlic, etc. [Archer and Discombe (1937) , Paton and Eaton (1937) [Hageman and Blake (1938) ]. Hallam (1939) 4-6^0 A-0 
